期刊文献+

纳米碳在甲状腺全切联合Ⅵ区淋巴清扫术中的应用研究 被引量:11

Application of carbon nano-particles in total thyroidectomy combined with lymphadenectomy in area Ⅵ
原文传递
导出
摘要 目的探讨在甲状腺乳头状癌全切联合Ⅵ区淋巴清扫术中应用纳米碳混悬注射液对甲状旁腺保护及淋巴清扫的作用。方法回顾性分析南京医科大学附属肿瘤医院头颈外科2016年4月至2018年1月完成的194例接受甲状腺全切+Ⅵ区淋巴清扫术的甲状腺乳头状癌患者,其中术中应用纳米碳的作为纳米碳组104例,常规手术的作为对照组90例。比较两组患者Ⅵ区及右侧Ⅵb区淋巴清扫数量、转移淋巴结数、术后(1 d、3 d、1个月及6个月)低钙血症及甲状旁腺功能减退发生率以及甲状旁腺误切率。采用卡方和秩和检验对数据进行分析。结果两组患者在年龄、性别、肿瘤大小、手术时间、肿瘤是否外侵以及是否多灶等方面比较差异无统计学意义,两组患者出现暂时性甲状旁腺功能减退的例数分别为纳米碳组28例(26.9%),对照组41例(45.5%),差异有统计学意义(χ^2=7.3,P=0.007),纳米碳组出现2例(1.9%)甲状旁腺误切,对照组出现8例(8.9%)甲状旁腺误切,差异有统计学意义(χ^2=4.9,P=0.026)。两组清扫出的Ⅵ区淋巴结枚数分别为791枚和536枚(Z=-2.2,P=0.028),右侧Ⅵb区淋巴结枚数分别为93枚和41枚(Z=-2.1,P=0.034),差异均有统计学意义。结论纳米碳在甲状腺乳头状癌甲状腺全切联合Ⅵ区淋巴清扫术中可以有效辨识及保护甲状旁腺,预防术后甲状旁腺功能低下的发生,并提高Ⅵ区淋巴结的清扫效果。 Objective To evaluate the effects of staining with carbon nanoparticles on the identification of parathyroid glands and lymph nodes during thyroid carcinoma surgery combined with lymphadenectomy.Methods A total of 194 patients with papillary thyroid carcinoma who underwent thyroidectomy combined with lymphadenectomy from April 2016 to January 2018 were reviewed. Of them 104 cases were injected with carbon nanoparticles in operation area (nanocarbon group) and other 90 cases without the injection of carbon nanoparticles were as control group. The incidence of mistakenly dissection of parathyroid glands and the levels of serum calcium and parathyroid hormone in 1 day, 3 days, 1 month and 6 months after surgery were compared between two groups of patients. Chisquare and ranksum test were used to analyze 2 data.Results There were no significant differences in age, gender, tumor size, operation time, extrathyroidal invasion and multifocality between two groups. Compared with control groups, nanocarbon group showed a significantly lower incidence of mistakenly dissection of parathyroid glands (8 cases vs 2 cases, 8.9% vs 1.9%,χ^2=4.9, P=0.026) and a significantly lower incidence of hypoparathyroidism (41 cases vs 28 cases, 45.5% vs 26.9%, χ^2=7.3, P=0.007). The number of lymph nodes dissected from central compartment was 791 in nanocarbon group and 536 in control groups, with a statistically significant difference (Z=-2.2, P=0.028). There was a significant difference in the number of lymph nodes removed from the right neck Ⅵb level between nanocarbon group and control group (41 nodes vs 93 nodes, Z=-2.1, P=0.034).Conclusion Treatment with nanocarbon can significantly facilitate the identification of the parathyroid during total thyroidectomy combined with central compartment lymphadenectomy, reduce the incidence of postoperative hypoparathyroidism, and improve the dissection of lymph node in the central compartment.
作者 钱亦淳 刘方舟 姚卫萍 赵炎斌 蒋媛 张园 Qian Yichun;Liu Fangzhou;Yao Weiping;Zhao Yanbin;Jiang Yuan;Zhang Yuan(Department of Head and Neck Surgery,the Affiliated Cancer Hospital of Nanjing Medical University,Nanjing 210009,China)
出处 《中华耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2019年第1期28-32,共5页 Chinese Journal of Otorhinolaryngology Head and Neck Surgery
基金 江苏省科技厅重点研发计划(BE2016796).
关键词 甲状腺肿瘤 乳头状 纳米碳 染色与标记 甲状旁腺 Thyroid neoplasms Carcinoma, papillary Carbon nanoparticles Staining and labeling Parathyroid glands
  • 相关文献

参考文献4

二级参考文献53

  • 1ZHURui-sen YUYong-li LUHan-kui LUOQuan-yong CHENLi-bo.Clinical study of 312 cases with matastatic differentiated thyroid cancer treated with large doses of ^(131)I[J].Chinese Medical Journal,2005(5):425-428. 被引量:10
  • 2傅锦业,吴毅,王卓颖,安勇,孙团起,向俊.未发现淋巴结转移的甲状腺乳头状癌中央区淋巴结清扫的临床病理分析[J].中华外科杂志,2007,45(7):470-472. 被引量:27
  • 3Fritze D,Doherty GM.Surgical management of cervical lymph nodes in differentiated thyroid cancer.Otolarygol Clin N Am,2010,43:285-300.
  • 4Shaha AR.Extent of surgery for papillary thyroid carcinoma.Arch Otolaryngul Head Neck Surg,2010,136:1061-1063.
  • 5Haaney CP,Amedee RG.What is the appropriate extent of lateral neck dissection in the treatment of metastatic well-differentiated thyroid carcinoma? Laryngoscope,2010,120:1716-1717.
  • 6Carty SE,Cooper DS,Doherty GM,et al.Consensus statement on the terminology and classification of central neck dissection for thyroid cancer.Thyroid,2009,19:1153-1158.
  • 7Robbins KT,Shaha AR,Medina JE,et al.Consensus statement on the classification and terminology of neck dissection.Arch Otolaryngol Head Neck Surg,2008,134:536-538.
  • 8Mazzaferri EL,Doherty GM,Steward DL.The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma.Thyroid,2009,19:683-689.
  • 9lyer NG,Kumar A,Nixon IJ,et al.Incidence and significance of Delphian node metastasis in papillary thyroid cancer.Ann Surg,2011,253:988-991.
  • 10Iyer NG,Shaha AR.Central compartment dissection for well differentiated thyroid cancer..and the band plays on.Curr Opin Otolaryngol Head Neck Surg,2011,19:106-112.

共引文献993

同被引文献99

引证文献11

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部